ASP Isotopes Corporate Overview 2024 | Isotope Enrichment Technology

ASP Isotopes Inc. is an advanced isotope enrichment company leveraging 20 years of R&D to supply enriched isotopes across medical, semiconductor, and nuclear energy markets. The company targets the medical isotopes market, projected to grow from $5.1 billion in 2022 to $11.4 billion by 2032, while supplying Silicon-28 to the semiconductor industry and uranium enrichment solutions through its Quantum Leap Energy subsidiary.